Philip Rosenfeld is an Ophthalmology physician. ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics need a complete publication history and a confident author match. We omit them when either check fails. Why? →
Clinical & industry
trials, payments and federal fundingClinical trials
- Complement Inhibition With Eculizumab for the Treatment of Non-Exudative Macular Degeneration (AMD)
Sponsor: Philip J. Rosenfeld, MD, PhD
- An OCT-Guided Variable Dosing Regimen With Ranibizumab for the Treatment of Neovascular AMD
Sponsor: University of Miami
- Prospective OCT Study With Lucentis for Neovascular AMD (PrONTO Study)
Sponsor: University of Miami
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
12 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- NovartisProgram year20252 paymentsResearch$30,796openpaymentsdata.cms.gov ↗
- Carl Zeiss MeditecProgram year20252 payments$16,500openpaymentsdata.cms.gov ↗
- ApellisProgram year20254 payments
Services and research payments matched to this physician's NPI in CMS Open Payments. Meals, travel and gifts are counted in the company total and not listed here. Research funding is listed under each investigator the record names.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Robert Weinreb, MD
University of California San Diego
Emily Chew, MD
National Eye Institute
Harry Quigley, MD
Johns Hopkins University School of Medicine
Joel Schuman, MD
Wills Eye Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”